Methods of inhibiting leaderless protein export using...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/70 (2006.01) A61K 31/56 (2006.01)

Patent

CA 2242245

This invention provides methods of inhibiting the export of a leaderless protein from a cell by contacting the cell with a cardiac glycoside or aglycone derivative. Leaderless proteins include FGF-1, FGF-2, IL-1.alpha., IL- 1.beta. and factor XIIIa. These methods are useful in treatment of conditions, including tumors and diabetes.

Cette invention concerne des procédés d'inhibition de l'exportation d'une protéine sans séquence de tête à partir d'une cellule consistant à mettre la cellule en contact avec un dérivé glycoside ou aglyone cardiaque. Les protéines sans séquence de tête comprennent FGF-1, FGF-2, IL-1.alpha., IL-1.beta. et le facteur XIIIa. Ces procédés sont utiles dans le traitement d'états pathologiques, notamment de tumeurs et du diabète.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Methods of inhibiting leaderless protein export using... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of inhibiting leaderless protein export using..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of inhibiting leaderless protein export using... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1894336

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.